Compare BCYC & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCYC | MGPI |
|---|---|---|
| Founded | 2009 | 1941 |
| Country | United Kingdom | United States |
| Employees | N/A | 267 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 397.4M |
| IPO Year | 2019 | 1994 |
| Metric | BCYC | MGPI |
|---|---|---|
| Price | $5.04 | $18.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $14.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 562.4K | 261.0K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,782,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.24 | $16.45 |
| 52 Week High | $9.55 | $33.75 |
| Indicator | BCYC | MGPI |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 43.22 |
| Support Level | $5.03 | $16.45 |
| Resistance Level | $7.14 | $19.25 |
| Average True Range (ATR) | 0.31 | 0.73 |
| MACD | 0.07 | 0.36 |
| Stochastic Oscillator | 77.14 | 72.86 |
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.